a holding company which engages in the discovery and development of novel cell therapies for oncology and other indications
Industry Biotechnology
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTSM | 59.88 | 0.02 | +0.03% |
First Trust Enhanced Short Maturity ETF | |||
PCRB | 48.45 | 0.01 | +0.01% |
Putnam ESG Core Bond ETF | |||
MGOV | 20.02 | -0.01 | -0.04% |
First Trust Intermediate Gvt Opps ETF | |||
JANW | 33.35 | -0.02 | -0.07% |
AllianzIM US Large Cap Buffer20 Jan ETF | |||
BUYZ | 36.98 | -0.52 | -1.38% |
Franklin Disruptive Commerce ETF |
A.I.dvisor indicates that over the last year, LEGN has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LEGN jumps, then AXON could also see price increases.
Ticker / NAME | Correlation To LEGN | 1D Price Change % | ||
---|---|---|---|---|
LEGN | 100% | -4.26% | ||
AXON - LEGN | 37% Loosely correlated | -0.86% | ||
BGNE - LEGN | 34% Loosely correlated | -2.10% | ||
ALNY - LEGN | 33% Loosely correlated | -8.67% | ||
GOSS - LEGN | 33% Poorly correlated | -3.88% | ||
ORMP - LEGN | 33% Poorly correlated | -4.50% | ||
More |